2 Followers SGX:BFK - Pharmesis Intl (SGD 0.315) PHARMESIS INTERNATIONAL LTD.
Sector: Health Technology, Industry: Pharmaceuticals: Generic
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price) See related symbol P31


SGD 0.315    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

7 Jul 2020


Overview

7 Jul 2020

52 Wk Range: 0.115 - 0.625

Day's Range: 0.315 - 0.315

Last Volume: 0

Current Yield: 0%

Projected Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

7 Jul 2020

Metric BFK S.Median
Beta -0.2 0.11
VaR 79.58 50.24
E.Shortfall 139.2 76.72
Liquidity 0 396.64K

Fundamental

7 Jul 2020

PE: NA

Market Cap: 7.2M

Price Over Book: 0.604

Price Over Sales: 0.99

Return On Assets: -15.9%

Return On Equity: -23.2%

Shares By Insiders: 53.4%

General

CEO: Xue Dan Wu

Founded Year: 2003

Headquarters: Chengdu

Sector: Health Technology

Industry: Pharmaceuticals: Generic

Useful Links
Homepage

Description

Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The TCM segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment consists of agency products and internally manufactured products which are marketed through the distribution arm. The company was founded on September 29, 2003 and is headquartered in Chengdu, China.